The agency approved Truxima for three lymphoma indications, whereas European regulators approved it last year for all the same indications as the reference product, Roche's Rituxan.
Ever forget the difference between an IND, a Phase I and Phase II trial? The difference between protein expression and gene expression profiling? The National Cancer Institute has a nifty tutorial that breaks down the development process of new, targeted therapies in cancer. It’s a good resource for anyone – be it you, a friend, a colleague, a […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.